Theranostics 2021; 11(14):7128-7129. doi:10.7150/thno.62534

Erratum

CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis: Erratum

Wenzhi Shen1,2,✉, Xiaoyuan Zhang1,2, Jiaping Tang3, Zhixin Zhang4, Renle Du5, Dehong Luo6, Xiaoran Liu1, Yong Xia1, Yanping Li1, Shanshan Wang1, Siyuan Yan1, Wancai Yang1, Rong Xiang5, Na Luo3, Yunping Luo7, Jianjun Li2

1. Dept. of Pathology and Institute of Precision Medicine, Jining Medical University, Jining 272067, China.
2. Institute of Breast Research, Jining Medical University, Jining 272067, China.
3. Dept. of Anatomy and Histology, School of Medicine, Nankai University, Tianjin 300071, China.
4. Dept. of Gastrointestinal Surgery, Affiliated Hospital of Jining Medical University, Jining 272029, China.
5. Dept. of Immunology, School of Medicine, Nankai University, Tianjin 300071, China.
6. The First People's Hospital of Zunyi, Zunyi, 563002, China.
7. Dept. of Immunology, Institute of Basic Medical Science, Chinese Academy of Medical Science, School of Basic Medicine Peking Union Medical College, Beijing, 100005, China.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Citation:
Shen W, Zhang X, Tang J, Zhang Z, Du R, Luo D, Liu X, Xia Y, Li Y, Wang S, Yan S, Yang W, Xiang R, Luo N, Luo Y, Li J. CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis: Erratum. Theranostics 2021; 11(14):7128-7129. doi:10.7150/thno.62534. Available from https://www.thno.org/v11p7128.htm

File import instruction

Corrected-article in Theranostics, Volume 11, 2297